Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05161572` - Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer	Phase 2
Not yet recruiting	`NCT05996484` - Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma	Phase 2
Not yet recruiting	`NCT04520737` - Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases	N/A
Recruiting	`NCT06138496` - Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC	Phase 2
Not yet recruiting	`NCT05983094` - Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer	Phase 2
Terminated	`NCT04440982` - Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients	Phase 2
Recruiting	`NCT04028375` - Study of CT and MR in the Gastric Cancer
Recruiting	`NCT04588987` - Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma	Phase 2
Not yet recruiting	`NCT05993858` - Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC	Phase 2
Active, not recruiting	`NCT04666090` - Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma	Phase 2
Recruiting	`NCT04848454` - Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy	Phase 2
Recruiting	`NCT04062058` - A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer	Phase 2
Recruiting	`NCT06124378` - Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer	Phase 2
Not yet recruiting	`NCT06125223` - PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma
Not yet recruiting	`NCT06404736` - QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer	Phase 2
Not yet recruiting	`NCT06404463` - QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer	Phase 2
Recruiting	`NCT05371197` - Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer	Phase 2
Recruiting	`NCT06212440` - Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy	N/A
Completed	`NCT03178032` - Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas	Phase 1
Recruiting	`NCT02769104` - Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer	Phase 3

NCT number	NCT03192735
Study type	Interventional
Source	Fujian Medical University
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	September 1, 2017
Completion date	December 11, 2024

Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms